Borisch-Chappuis, B., Nezclof, C.. Muller, H. & Muller-Hermeling, H.K. (1990) Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. American Journal of Pathology. 136, 751-758.
Mortensen, L. (1996) Epstein-Barr virus genome in nonHodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood, 87, 1045-1055.
Gallard. F.. Mechinaux-Lacroix, E, Papin. S., Moreau, A., Mollat, C.. Fiche. M., Peltier. S.. Juin de Faucal, P., Rousselet. M.C., Praloran. V. & Harousseau, J.L. (1992) Primary Epstein-Barr infection with clonal T-cell lymphoproliferation. American Journal of Clinical Pathology. 98, 324-333.
Jones, J.F.. Shurin. S., Abramowsky. C.. Tubbs, R.. Sciotto. C.G., Wahl, R., Sands. J.. Gottman, D., Ktaz. B.Z. & Sklar, J. (1988) T-cell lymphomas containing Epstein-Barr viral DMA in patients with chronic Epstein-Barr virus infections. New England Journal of Medicine, 318, 733-741.
Seeker-Walter. L.M., Mehta, A. & Brain. B. (1995) Abnormalities of 3q21 and 3q26 in mycloid malignancy: a United Kingdom Cancer Cytogenetic Group study. British Journal ofHaematology. 91,490501.